CN1054986C - Chinese medicine pill for treating rheumatoid disease - Google Patents
Chinese medicine pill for treating rheumatoid disease Download PDFInfo
- Publication number
- CN1054986C CN1054986C CN95117932A CN95117932A CN1054986C CN 1054986 C CN1054986 C CN 1054986C CN 95117932 A CN95117932 A CN 95117932A CN 95117932 A CN95117932 A CN 95117932A CN 1054986 C CN1054986 C CN 1054986C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- rhizoma
- portions
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 239000006187 pill Substances 0.000 title claims abstract description 21
- 201000010099 disease Diseases 0.000 title abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000218671 Ephedra Species 0.000 claims abstract description 8
- 238000007796 conventional method Methods 0.000 claims abstract description 8
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims description 18
- 241000272205 Columba livia Species 0.000 claims description 15
- 235000019129 pluma Nutrition 0.000 claims description 15
- 244000291751 pluma del Caribe Species 0.000 claims description 15
- 235000019070 pluma del Caribe Nutrition 0.000 claims description 15
- 241000522620 Scorpio Species 0.000 claims description 14
- 239000009490 scorpio Substances 0.000 claims description 14
- 241000305492 Gastrodia Species 0.000 claims description 7
- 241000202807 Glycyrrhiza Species 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 16
- 239000000843 powder Substances 0.000 abstract 2
- 241000227129 Aconitum Species 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000272201 Columbiformes Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 210000003746 feather Anatomy 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 208000037920 primary disease Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000008822 Ankylosis Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004090 etiopathogenesis Effects 0.000 description 1
- 230000035929 gnawing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine pill for treating rheumatoid diseases. The pill takes angelica, dendrobe, wild ginger, notopterygium root, scorpion, gastrodiae, kusnezoff monkshood root, common monkshood mother root, hemlock parsley, realgar, ephedra, atractylodes rhizome, fleece-flower root and liquorice as the principal raw materials which are ground into fine powder by a conventional method; cornu procaprae gutturosae and pigeon feather are mixed into the fine powder after being incinerated by a traditional method in folk, and pills are obtained after honey with the gross weight of 1.2 to 1.3 times heavier than that of the raw materials is added. The pill has the advantages of convenient use and obvious curative effect.
Description
The invention belongs to the rheumatoid Chinese patent medicine of treatment, is to be the primary raw material rheumatoid medicine pill of the synthetic treatment of Mel with the Chinese herbal medicine specifically.
Rheumatoid disease is a kind of common frdquently encountered disease, and rheumatoid in the world at present sickness rate is about 0.25%, and China has more than 1,000 ten thousand people to suffer from this disease, and is very big to the health of people influence.
Rheumatoid disease is to be main chronic general immune disease with the arthropathy, and the joint each several part all can be invaded, the easiest the getting involved in particularly little joint.Primary disease in early days or acute stage, that the morbidity joint is is red, swollen, hot, bitterly and the dyskinesia, falls ill late period, often causes ankylosis or deformity, serious disability.Because the rheumatoid disease course of disease is grown, is difficult to radical cure, so Chinese and western medicine is all classified one of difficult treatment kind as.
At present, the problem that the Drug therapy of primary disease is run into is; Doctor trained in Western medicine is not owing to still illustrate fully the primary disease etiopathogenesis, so treatment adopts salicylic acid preparation and hormone based on relief of symptoms, but above-mentioned treatment means side effect is big, and curative effect is not consolidated; The Chinese medicine of treatment primary disease mostly is decoction and cooperates pill, takes inconvenience, the course of treatment is oversize, curative effect is not remarkable.
The purpose of this invention is to provide the short rheumatoid medicine pill of treatment of a kind of evident in efficacy, therapeutic process.
It is according to applicant's clinical practice of three more than ten years that medicine of the present invention is formed, and proposes in conjunction with ancient theory of Chinese medical science.The traditional Chinese medical science thinks, rheumatoid exopathogenic factor system is because the damp and hot heresy of wind and cold, and endogenous cause of ill and QI and blood, negative and positive, internal organs are relevant.Though the applicant thinks that primary disease is different in the different phase clinical manifestation of morbidity, but heat, poison, wind, wetly be main paathogenic factor, and be related mutually between four, heat, poison be the main diseases that causes arthritis because of, wind, wet cause that limb activity is limited, gnawing pains take no rest, so the present invention forms according to Therapeutic Principle's prescription of heat-clearing and toxic substances removing, antiinflammatory dampness removing, promoting blood circulation by removing wind, relieving spasm to stop pain.
In the component of the present invention; Herba Dendrobii, Rhizoma Et Radix Notopterygii, Realgar, Herba Ephedrae, Rhizoma Atractylodis are the product of detoxifcation heat clearing away, and the expelling wind and removing dampness function is arranged, and can eliminate arthritis; Radix Angelicae Sinensis, Herba Asari, Scorpio, Radix Aconiti, the Radix Polygoni Multiflori, Radix Glycyrrhizae have blood circulation promoting and dispersing pathogen accumulation, relieving spasm to stop pain effect, but dredging the meridian, loose and to separate stasis of blood heresy; Rhizoma Chuanxiong, Radix Aconiti Kusnezoffii, Rhizoma Gastrodiae are promoting blood circulation and stopping pain, the product of the circulation of qi promoting of dispeling the wind; To be that the wash rice river is among the people be used for the close side of heat clearing and inflammation relieving specially good effect for Cornu procaprae gutturosae, Pluma Columba livia, excellent to rheumatism inflammation effect.
This treats rheumatoid medicine pill is the pill of being made by following weight proportion raw material and method;
Radix Angelicae Sinensis 10-14 part Herba Dendrobii 10-14 part Herba Asari 7-9 part Rhizoma Et Radix Notopterygii 12-16 part
Scorpio 13-17 part Rhizoma Gastrodiae 18-22 part Radix Aconiti Kusnezoffii 10-14 part Radix Aconiti 10-14 part
Rhizoma Chuanxiong 10-14 part Realgar 10-14 part Herba Ephedrae 10-14 part Rhizoma Atractylodis 13-17 part
Radix Polygoni Multiflori 10-14 part Radix Glycyrrhizae 10-14 part Cornu procaprae gutturosae 2.5-3.5 part
Pluma Columba livia 1.5-2.5 part
Radix Angelicae Sinensis, Herba Dendrobii, Herba Asari, Rhizoma Et Radix Notopterygii, Scorpio, Rhizoma Gastrodiae, Radix Aconiti Kusnezoffii, Radix Aconiti, Rhizoma Chuanxiong, Realgar, Herba Ephedrae, Rhizoma Atractylodis, the Radix Polygoni Multiflori, the Radix Glycyrrhizae of said ratio are ground into thin medicamental pulverata according to a conventional method, Cornu procaprae gutturosae, the Pluma Columba livia of said ratio are incinerated, admix in the thin medicamental pulverata that is ground into, the Mel that adds weight again and be 1.2 to 1.3 times of above-mentioned raw materials gross weights is made pill according to conventional method of Chinese medicinal, and every ball 10 grams are for good.
The optimum weight proportioning of each raw material of the rheumatoid medicine pill of above-mentioned treatment and Mel is;
14 parts of 8 portions of Rhizoma Et Radix Notopterygiis of 12 parts of Herba Asaris of 12 parts of Herba Dendrobiis of Radix Angelicae Sinensis
12 parts of 12 portions of Radix Aconitis of 20 portions of Radix Aconiti Kusnezoffii of 15 parts of Rhizoma Gastrodiaes of Scorpio
15 parts of 12 parts of Rhizoma Atractylodis of 12 portions of Herba Ephedraes of 12 portions of Realgars of Rhizoma Chuanxiong
2 parts of 3 parts of Pluma Columba livia of 12 parts of Cornu procaprae gutturosaes of 12 portions of Radix Glycyrrhizaes of the Radix Polygoni Multiflori
222 to 240.5 parts of Mel are with 231 parts of the bests
Everyone once obeys one to this medicine to general rheumatoid patient, and clothes were three times in one day.Child and old man are cut down according to the circumstance, and obey the 1/2-2/3 ball at every turn.Be not taken by pregnant women.Other Western medicine of stopping using gradually in the process of this medicine of clothes, is added up therapeutic effect three courses of treatment at month course of treatment of this medication.
Because this medicine is because of heat-clearing and toxic substances removing, antiinflammatory dampness removing, promoting blood circulation by removing wind, relieving spasm to stop pain at rheumatoid disease, not only met the basic theories of Chinese traditional treatment arthromyodynia but also improve and regulate the effect of whole body negative and positive, not only take stopgap measures but also effect a permanent cure, the Cornu procaprae gutturosae of treatment inflammation of use among the people and the effect that Pluma Columba livia is got both clearing away heat-fires have particularly courageously been adopted, for eliminate the rheumatoid arthrosis inflammation, to improve the clinical symptoms effect very good, makes the present invention obtain ideal curative effect to rheumatoid disease.163 routine rheumatoid patients are obeyed the medicine pill of the present invention curative effect of three courses of treatment, with reference to " standard of national combination of Chinese and Western medicine rheumatoid disease association revision " statistics in 1988, clinical cure 41 examples account for 25.1%, produce effects 63 examples account for 38.6%, 46 examples that take a turn for the better account for 28.4%, invalid 13 examples account for 7.9%, and total effective rate is 92.1%, and are evident in efficacy, clinical cure rate is high; Rheumatoid disease state of an illness after treating is difficult to consolidate, the patient follow-up of applicant after to 54 example treatments, and the rate of consolidating half a year reaches 94.4%, one year, and to consolidate rate be 77.8%, this medication imitates that to consolidate rate better; This medicine is used for people surplus the rheumatoid disease patient 5000, and the property of medicine is gentle, do not have untoward reaction, safe and reliable, patient is easy to accept.
See following table for details by disease degree curative effect statistics
The concrete weight proportion of each raw material of medicine pill of the present invention and Mel is provided by embodiment.
Every part of weight is 1 kilogram among following each embodiment.
Embodiment one;
12 parts of 7 portions of Rhizoma Et Radix Notopterygiis of 10 parts of Herba Asaris of 10 parts of Herba Dendrobiis of Radix Angelicae Sinensis
10 parts of 10 portions of Radix Aconitis of 18 portions of Radix Aconiti Kusnezoffii of 13 parts of Rhizoma Gastrodiaes of Scorpio
13 parts of 10 parts of Rhizoma Atractylodis of 10 portions of Herba Ephedraes of 10 portions of Realgars of Rhizoma Chuanxiong
1.5 parts of 2.5 parts of Pluma Columba livia of 10 parts of Cornu procaprae gutturosaes of 10 portions of Radix Glycyrrhizaes of the Radix Polygoni Multiflori
Radix Angelicae Sinensis, Herba Dendrobii, Herba Asari, Rhizoma Et Radix Notopterygii, Scorpio, Rhizoma Gastrodiae, Radix Aconiti Kusnezoffii, Radix Aconiti, Rhizoma Chuanxiong, Realgar, Herba Ephedrae, Rhizoma Atractylodis, the Radix Polygoni Multiflori, the Radix Glycyrrhizae of said ratio are ground into thin medicamental pulverata according to a conventional method, Cornu procaprae gutturosae, the Pluma Columba livia of said ratio are incinerated, admix in the thin medicamental pulverata that is ground into, add 188 parts of Mel again and make pill, every ball 10 grams according to conventional method of Chinese medicinal.
Embodiment two;
16 parts of 9 portions of Rhizoma Et Radix Notopterygiis of 14 parts of Herba Asaris of 14 parts of Herba Dendrobiis of Radix Angelicae Sinensis
14 parts of 14 portions of Radix Aconitis of 22 portions of Radix Aconiti Kusnezoffii of 17 parts of Rhizoma Gastrodiaes of Scorpio
17 parts of 14 parts of Rhizoma Atractylodis of 14 portions of Herba Ephedraes of 14 portions of Realgars of Rhizoma Chuanxiong
2.5 parts of 3.5 parts of Pluma Columba livia of 14 parts of Cornu procaprae gutturosaes of 14 portions of Radix Glycyrrhizaes of the Radix Polygoni Multiflori
277 parts of Mel
Embodiment three;
16 parts of 9 portions of Rhizoma Et Radix Notopterygiis of 10 parts of Herba Asaris of 10 parts of Herba Dendrobiis of Radix Angelicae Sinensis
14 parts of 14 portions of Radix Aconitis of 18 portions of Radix Aconiti Kusnezoffii of 13 parts of Rhizoma Gastrodiaes of Scorpio
17 parts of 14 parts of Rhizoma Atractylodis of 10 portions of Herba Ephedraes of 10 portions of Realgars of Rhizoma Chuanxiong
2.5 parts of 3.5 parts of Pluma Columba livia of 10 parts of Cornu procaprae gutturosaes of 10 portions of Radix Glycyrrhizaes of the Radix Polygoni Multiflori
220 parts of Mel
Embodiment four;
12 parts of 7 portions of Rhizoma Et Radix Notopterygiis of 14 parts of Herba Asaris of 14 parts of Herba Dendrobiis of Radix Angelicae Sinensis
10 parts of 10 portions of Radix Aconitis of 22 portions of Radix Aconiti Kusnezoffii of 17 parts of Rhizoma Gastrodiaes of Scorpio
13 parts of 10 parts of Rhizoma Atractylodis of 14 portions of Herba Ephedraes of 14 portions of Realgars of Rhizoma Chuanxiong
1.5 parts of 2.5 parts of Pluma Columba livia of 14 parts of Cornu procaprae gutturosaes of 14 portions of Radix Glycyrrhizaes of the Radix Polygoni Multiflori
241 parts of Mel
Embodiment five;
14 parts of 8 portions of Rhizoma Et Radix Notopterygiis of 12 parts of Herba Asaris of 12 parts of Herba Dendrobiis of Radix Angelicae Sinensis
12 parts of 12 portions of Radix Aconitis of 20 portions of Radix Aconiti Kusnezoffii of 15 parts of Rhizoma Gastrodiaes of Scorpio
15 parts of 12 parts of Rhizoma Atractylodis of 12 portions of Herba Ephedraes of 12 portions of Realgars of Rhizoma Chuanxiong
2 parts of 3 parts of Pluma Columba livia of 12 parts of Cornu procaprae gutturosaes of 12 portions of Radix Glycyrrhizaes of the Radix Polygoni Multiflori
231 parts of Mel
Embodiment two, three, four, five is ground into thin medicamental pulverata according to a conventional method according to the Radix Angelicae Sinensis of proportioning among each embodiment, Herba Dendrobii, Herba Asari, Rhizoma Et Radix Notopterygii, Scorpio, Rhizoma Gastrodiae, Radix Aconiti Kusnezoffii, Radix Aconiti, Rhizoma Chuanxiong, Realgar, Herba Ephedrae, Rhizoma Atractylodis, the Radix Polygoni Multiflori, Radix Glycyrrhizae, Cornu procaprae gutturosae, the Pluma Columba livia of each embodiment weight proportion are incinerated, admix in the thin medicamental pulverata that is ground into, add the pill that weight is made according to conventional method of Chinese medicinal for the Mel of each embodiment proportioning again.
Claims (2)
1, the rheumatoid medicine pill of a kind of treatment is characterized in that: it is pill Radix Angelicae Sinensis 10-14 part Herba Dendrobii 10-14 part Herba Asari 7-9 part Rhizoma Et Radix Notopterygii 12-16 part Scorpio 13-17 part Rhizoma Gastrodiae 18-22 part Radix Aconiti Kusnezoffii 10-14 part Radix Aconiti 10-14 part Rhizoma Chuanxiong 10-14 part Realgar 10-14 part Herba Ephedrae 10-14 part Rhizoma Atractylodis 13-17 part Radix Polygoni Multiflori 10-14 part Radix Glycyrrhizae 10-14 part Cornu procaprae gutturosae 2.5-3.5 part Pluma Columba livia 1.5-2.5 part of making according to following weight proportion raw material and method
Radix Angelicae Sinensis, Herba Dendrobii, Herba Asari, Rhizoma Et Radix Notopterygii, Scorpio, Rhizoma Gastrodiae, Radix Aconiti Kusnezoffii, Radix Aconiti, Rhizoma Chuanxiong, Realgar, Herba Ephedrae, Rhizoma Atractylodis, the Radix Polygoni Multiflori, the Radix Glycyrrhizae of said ratio are ground into thin medicamental pulverata according to a conventional method, Cornu procaprae gutturosae, the Pluma Columba livia of said ratio are incinerated, admix in the thin medicamental pulverata that is ground into, the Mel that adds weight again and be 1.2 to 1.3 times of above-mentioned raw materials gross weights method of Chinese medicinal is routinely made pill.
2, the rheumatoid medicine pill of treatment according to claim 1 is characterized in that; Its raw material weight proportioning is
14 parts of 8 portions of Rhizoma Et Radix Notopterygiis of 12 parts of Herba Asaris of 12 parts of Herba Dendrobiis of Radix Angelicae Sinensis
12 parts of 12 portions of Radix Aconitis of 20 portions of Radix Aconiti Kusnezoffii of 15 parts of Rhizoma Gastrodiaes of Scorpio
15 parts of 12 parts of Rhizoma Atractylodis of 12 portions of Herba Ephedraes of 12 portions of Realgars of Rhizoma Chuanxiong
2 parts of 3 parts of Pluma Columba livia of 12 parts of Cornu procaprae gutturosaes of 12 portions of Radix Glycyrrhizaes of the Radix Polygoni Multiflori
222 to 240.5 parts of Mel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95117932A CN1054986C (en) | 1995-11-02 | 1995-11-02 | Chinese medicine pill for treating rheumatoid disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95117932A CN1054986C (en) | 1995-11-02 | 1995-11-02 | Chinese medicine pill for treating rheumatoid disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1131557A CN1131557A (en) | 1996-09-25 |
| CN1054986C true CN1054986C (en) | 2000-08-02 |
Family
ID=5081465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95117932A Expired - Fee Related CN1054986C (en) | 1995-11-02 | 1995-11-02 | Chinese medicine pill for treating rheumatoid disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1054986C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066342C (en) * | 1998-02-12 | 2001-05-30 | 陈正中 | Zhengzhong rheumatism expelling pellet |
| CN106377677A (en) * | 2016-12-06 | 2017-02-08 | 郑州郑先医药科技有限公司 | Medicine for curing rheumatism and preparation method thereof |
| CN119454465B (en) * | 2024-11-13 | 2025-11-07 | 江西奉真堂中医药科技有限公司 | Preparation process of licorice particles |
-
1995
- 1995-11-02 CN CN95117932A patent/CN1054986C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 《中药大辞典》第一版 1986.1.1 江苏新医学院，上海科学技术出版社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1131557A (en) | 1996-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN1193775C (en) | Rheumatoid disease treating capsule | |
| CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1054773C (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease | |
| CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN1223886A (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN1141114C (en) | Tendon-conditioning analgetic | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1181879C (en) | Analgestic plaster | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1698735A (en) | Medicine for treating psoriasis | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN1190215C (en) | Chinese medicine for treating rheumatism | |
| CN102872293A (en) | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease | |
| CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof | |
| CN1162163C (en) | Chinese herbal medicinal liquor for curing rheumatic arthritis | |
| CN100344317C (en) | Gastrodia tuber capsule and its preparation process | |
| CN1130220C (en) | Chinese medicine 'Shexianfengshi wan' |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |